Azzalini, E.; Tierno, D.; Bartoletti, M.; Barbazza, R.; Giorda, G.; Puglisi, F.; Cecere, S.C.; Losito, N.S.; Russo, D.; Stanta, G.;
et al. AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization. Cancers 2022, 14, 304.
https://doi.org/10.3390/cancers14020304
AMA Style
Azzalini E, Tierno D, Bartoletti M, Barbazza R, Giorda G, Puglisi F, Cecere SC, Losito NS, Russo D, Stanta G,
et al. AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization. Cancers. 2022; 14(2):304.
https://doi.org/10.3390/cancers14020304
Chicago/Turabian Style
Azzalini, Eros, Domenico Tierno, Michele Bartoletti, Renzo Barbazza, Giorgio Giorda, Fabio Puglisi, Sabrina Chiara Cecere, Nunzia Simona Losito, Daniela Russo, Giorgio Stanta,
and et al. 2022. "AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization" Cancers 14, no. 2: 304.
https://doi.org/10.3390/cancers14020304
APA Style
Azzalini, E., Tierno, D., Bartoletti, M., Barbazza, R., Giorda, G., Puglisi, F., Cecere, S. C., Losito, N. S., Russo, D., Stanta, G., Canzonieri, V., & Bonin, S.
(2022). AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization. Cancers, 14(2), 304.
https://doi.org/10.3390/cancers14020304
